Navigation Links
WebMD to Present at the Goldman Sachs Technology and Internet Conference 2010

NEW YORK, Feb. 19 /PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD) today announced that executives of WebMD are scheduled to participate at the Goldman Sachs Technology and Internet Conference 2010 on Wednesday, February 24, 2010 at 12:40 p.m. ET.  

Investors, analysts and the general public are invited to listen to a live audio broadcast of the presentation over the Internet.  The broadcast can be accessed at (in the Investor Relations section). A replay of the broadcast will be available at the same web address.

About WebMD

WebMD Health Corp. (Nasdaq: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portals and health-focused publications. Approximately 60 million unique visitors access the WebMD Health Network each month.

The WebMD Health Network includes WebMD Health, Medscape, MedicineNet, emedicine, emedicineHealth, RxList, and

All statements contained in this press release, other than statements of historical fact, are forward-looking statements. These statements are based on WebMD's current plans and expectations and involve risks and uncertainties, including those described in our SEC filings.


Back to top



Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. WebMD Announces Fourth Quarter Financial Results
2. WebMD Launches New Version of Free Mobile Application for Physicians
3. WebMD to Present at the 12th Annual Needham Growth Stock Conference
4. WebMD Health Corp. Announces Preliminary Results of Its Tender Offer
5. WebMD Announces Third Quarter Financial Results
6. FDA and WebMD Expand Consumer Health Information Partnership
7. WebMD to Present at the Canaccord Adams 29th Annual Global Growth Conference
8. WebMD Announces Second Quarter Financial Results
9. WebMD Launches Free Mobile Application For Physicians
10. HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call
11. HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: